OUR PARTNERS
RJ Founded in 1929 in Spain, Reig Jofre is a leading industrial group in the European pharmaceutical market. Family owned, it has more than 600 employees and strong growth over the last years.
The structure includes four divisions:
- Industrial Services Division
- Pharma Division
- R&D and Regulatory Division
- RJ Biotech Services
Pharmalink is a Spanish company that focuses on the manufacture of medical devices, food supplements and cosmetics.
Pharmalink is the result of the long experience of its professional team in the pharmaceutical, cosmetic and related industries.
It has a production plant of 5.000m2 equipped with modern technology and fully automated machines.
Pharmalink aims to provide comprehensive and flexible solutions to customers, controlling the entire value chain of the product, from design to logistics.
Pharmalink is offering to its customers products with high added value without any other intermediary
Bioplax Ltd. is a young R&D company that specialises in oral care.
The first line of products manufactured by the company is currently marketed under the trademark Aftamed®. It is also sold in some countries under the name of Bloxaphte®, Gum Aftamed®, Aftex®, Aftaspray® or Aftum®.
The company’s strong points are its international patents, health registrations in various countries, and clinical and scientific evidence (ie. the quality, safety and efficacy of its products).
Headquarters in Athens, Greece Founded in 1969 by Nicolaos Katsos, it is one of the fastest growing pharmaceutical companies in Greece.
With 3 ultra-modern research laboratories and 2 industrial units.
The company’s workforce is made up of more than 650 employees working in the fields of Research & Development (R&D), production, and promotion of pharmaceutical products for more than 85 countries worldwide.
Today Pharmathen’s products are approved in all EU countries and their distribution rights are granted to the biggest pharmaceutical companies in the world, particularly in Europe, the United States of America and Canada.
Pharmathen’s sales amounted to €115 million in 2009; it ranks as the number 1 company in Greece in terms of revenues.
The Cigalah Group head quartered in Jeddah is made up several companies and divisions covering a diversified range of activities which include:
- Consumer Products (FMCG)
- Pharmaceuticals & Healthcare
- Watch, Textile & Retail
- Food Production and Packaging
Cigalah was established in the late 1980’s initially as marketing, sales and distribution company, whose overall philosophy put simply was “To Put the Right Products on Shelves…in the Best Possible Light, and with the Best Marketing Support, so that Consumers Would Buy Them” This basic philosophy remains the same and has been the foundation of the group’s success.
But since that time Cigalah has recognised the development of the markets in terms of requirements for products and services. Accordingly has grown and expanded into several diversified sectors from consumerable and non-consumerable retail products to healthcare (products and services) and manufacturing. This has resulted in Cigalah being now a fully structured group of self sufficient companies and divisions.